Literature DB >> 22294368

Mouse models of human bladder cancer as a tool for drug discovery.

Catherine Seager1, Anna M Puzio-Kuter, Carlos Cordon-Cardo, James McKiernan, Cory Abate-Shen.   

Abstract

Muscle-invasive bladder cancer is a deadly condition in dire need of effective new treatments. This unit contains a description of mouse models suitable for the evaluation of potential new therapies. Included is a genetically engineered mouse model of bladder cancer generated by the delivery of an adenovirus expressing Cre recombinase into the bladder lumen. Also described is an orthotopic mouse model created by the instillation of human bladder tumor cells into the bladder lumen of immune deficient mice. Protocols are also provided on the use of these models for the preclinical evaluation of new chemical entities, with mTOR inhibitors shown as an example.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22294368      PMCID: PMC3272628          DOI: 10.1002/0471141755.ph1414s49

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  26 in total

1.  Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene.

Authors:  Ralf Lesche; Matthias Groszer; Jing Gao; Ying Wang; Albee Messing; Hong Sun; Xin Liu; Hong Wu
Journal:  Genesis       Date:  2002-02       Impact factor: 2.487

Review 2.  Focus on bladder cancer.

Authors:  Colin P N Dinney; David J McConkey; Randall E Millikan; Xifeng Wu; Menashe Bar-Eli; Liana Adam; Ashish M Kamat; Arlene O Siefker-Radtke; Tomasz Tuziak; Anita L Sabichi; H Barton Grossman; William F Benedict; Bogdan Czerniak
Journal:  Cancer Cell       Date:  2004-08       Impact factor: 31.743

3.  Techniques for mammalian cell tissue culture.

Authors:  Mary C Phelan
Journal:  Curr Protoc Mol Biol       Date:  2006-05

4.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

5.  Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

Authors:  J Jonkers; R Meuwissen; H van der Gulden; H Peterse; M van der Valk; A Berns
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

6.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

Review 7.  Mouse models of brain tumors and their applications in preclinical trials.

Authors:  Elena I Fomchenko; Eric C Holland
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

Review 8.  Bladder cancer subtypes defined by genomic alterations.

Authors:  Margaret A Knowles
Journal:  Scand J Urol Nephrol Suppl       Date:  2008-09

9.  Genetic alterations in bladder cancer.

Authors:  G Dalbagni; J Presti; V Reuter; W R Fair; C Cordon-Cardo
Journal:  Lancet       Date:  1993-08-21       Impact factor: 79.321

Review 10.  Molecular pathogenesis and diagnostics of bladder cancer.

Authors:  Anirban P Mitra; Richard J Cote
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

View more
  5 in total

1.  ATDC/TRIM29 Drives Invasive Bladder Cancer Formation through miRNA-Mediated and Epigenetic Mechanisms.

Authors:  Phillip L Palmbos; Lidong Wang; Huibin Yang; Yin Wang; Jacob Leflein; McKenzie L Ahmet; John E Wilkinson; Chandan Kumar-Sinha; Gina M Ney; Scott A Tomlins; Stephanie Daignault; Lakshmi P Kunju; Xue-Ru Wu; Yair Lotan; Monica Liebert; Mats E Ljungman; Diane M Simeone
Journal:  Cancer Res       Date:  2015-10-15       Impact factor: 12.701

Review 2.  Modelling bladder cancer in mice: opportunities and challenges.

Authors:  Takashi Kobayashi; Tomasz B Owczarek; James M McKiernan; Cory Abate-Shen
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

Review 3.  Preclinical Models for Bladder Cancer Research.

Authors:  Shaoming Zhu; Zheng Zhu; Ai-Hong Ma; Guru P Sonpavde; Fan Cheng; Chong-Xian Pan
Journal:  Hematol Oncol Clin North Am       Date:  2021-04-16       Impact factor: 2.861

4.  Tsc1-Tp53 loss induces mesothelioma in mice, and evidence for this mechanism in human mesothelioma.

Authors:  Y Guo; L R Chirieac; R Bueno; H Pass; W Wu; I A Malinowska; D J Kwiatkowski
Journal:  Oncogene       Date:  2013-07-15       Impact factor: 9.867

5.  An improved mouse orthotopic bladder cancer model exhibiting progression and treatment response characteristics of human recurrent bladder cancer.

Authors:  Tomoharu Naito; Tamami Higuchi; Yasuhiro Shimada; Chihaya Kakinuma
Journal:  Oncol Lett       Date:  2019-12-02       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.